MED-Pharma SPRL
MED-Pharma reported total assets of 892,951 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of MED-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MED-Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 33,279 € | ||||
| Equity | 776,569 € | ||||
| Cash | 4,588 € | ||||
| EBITDA | 36,797 € | ||||
| Total assets | 892,951 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 05 Nov 2024
- Year ended 31 Dec 2022filed on 24 Oct 2023
- Year ended 31 Dec 2021filed on 29 Oct 2022
MED-Pharma's financial analysis
- Solvency87.0%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MED-Pharma
MED-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0818.652.680
- VAT number
- BE0818652680
- Peppol
- Registered · 0208:0818652680 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 18 Sep 2009
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
MED-Pharma (SPRL) has been based in Anderlecht since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 33,279 € and equity of 776,569 €; its revenue is not published. Its solvency stands at 87.0%, above the median of its sector (37.6%).
Companies similar to MED-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Bayna Retail sale of pharmaceutical products Saint-Gilles · balance sheet 674,880 €
- Apotheek De Zeshoek Retail sale of pharmaceutical products Turnhout · balance sheet 907,102 €
- Geassocieerde Apotheek VAN Puyvelde Retail sale of pharmaceutical products Antwerp · balance sheet 908,969 €
- PhilClapharma Retail sale of pharmaceutical products Tervuren · balance sheet 867,932 €
- Cosom Retail sale of pharmaceutical products Genappe · balance sheet 931,343 €
- Cassifarma Retail sale of pharmaceutical products Leuven · balance sheet 942,826 €
- Verkest - Lesage Retail sale of pharmaceutical products Roeselare · balance sheet 845,357 €
- Akaption Retail sale of pharmaceutical products Braives · balance sheet 967,311 €
Frequently asked questions about MED-Pharma
What is the revenue of MED-Pharma?
MED-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MED-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0818652680 for MED-Pharma, if the company is VAT-registered. Its company number (CBE) is 0818.652.680.
Where is the registered office of MED-Pharma?
According to the CBE register, the registered office of MED-Pharma is in 1070 Anderlecht.
What is the equity of MED-Pharma?
At the close of the 2025 financial year, the equity of MED-Pharma amounts to 776,569 €, a solvency of 87.0% of total assets.
Who manages MED-Pharma?
The register lists 1 active mandates at MED-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MED-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →